ursodeoxycholic acid has been researched along with Bowel Diseases, Inflammatory in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 8 (23.53) | 29.6817 |
| 2010's | 22 (64.71) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Bik, E; Milkiewicz, P; Wronka, KM | 1 |
| Cipullo, M; Dallio, M; Federico, A; Gravina, AG; Iadanza, G; Olivieri, S; Panarese, I; Pellegrino, R; Romeo, M | 1 |
| Keely, SJ; Lajczak-McGinley, NK; Steer, CJ | 1 |
| Curley, C; Fallon, CM; Keely, SJ; Lajczak-McGinley, NK; McCarron, PA; Porru, E; Roda, A; Smyth, J; Tambuwala, MM | 1 |
| Carey, EJ; Horsley-Silva, JL; Lindor, KD | 1 |
| Kowdley, KV; Lashner, B; Rao, BB | 1 |
| Mieli-Vergani, G; Terziroli Beretta-Piccoli, B; Vergani, D | 1 |
| Bergquist, A; Bottai, M; Höijer, J; Söderberg-Löfdal, K; Stokkeland, K | 1 |
| Khanna, S; Loftus, EV; Pardi, DS; Singh, S; Talwalkar, JA | 1 |
| Halai, UA; Hansen, JD; Kumar, S; Lo, WK; Poulsen, DM; Tater, KC | 1 |
| Han, SH; Lee, J | 1 |
| Datta, S; De, AK; Mukherjee, A; Sana, S | 1 |
| Chapman, CG; Rubin, DT | 1 |
| Leong, RW; Wang, R | 1 |
| Fisher, SE; Rabinowitz, SS; Schwarz, SM; Vo, HD; Xu, J | 1 |
| Harrison, ME; Kowdley, KV; Lindor, KD | 1 |
| Ballet, V; Falony, G; Ferrante, M; Joossens, M; Machiels, K; Raes, J; Sabino, J; Van Assche, G; Van der Merwe, S; Vermeire, S; Vieira-Silva, S | 1 |
| De Vos, M; Devisscher, L; Devriese, S; Hindryckx, P; Holvoet, T; Laukens, D; Pieper, DH; Van de Wiele, T; Van den Bossche, L; Van Welden, S; Vanden Bussche, J; Vanhaecke, L; Vilchez-Vargas, R; Vital, M | 1 |
| Knight, C; Murray, KF | 1 |
| Eksteen, B; Goh, J; Kane, K; Love, M; Low, A; Walt, R | 1 |
| Gotthardt, D; Kloeters-Plachky, P; Kulaksiz, H; Rost, D; Rudolph, G; Stiehl, A | 1 |
| Boberg, KM; Karlsen, TH; Schrumpf, E | 1 |
| Ponsioen, CY | 2 |
| Bergquist, A; Boberg, KM; Castedal, M; Cvancarova, M; Foss, A; Friman, S; Holte, K; Isoniemi, H; Jørgensen, KK; Lindström, L; Nordin, A; Rasmussen, A; Schrumpf, E; Vatn, MH | 1 |
| Kiss, LS; Lakatos, L; Lakatos, PL; Peyrin-Biroulet, L; Schoepfer, A; Vavricka, S | 1 |
| Jaikishen, JP; Lamarche, MB; Sokol, L; Stueben, ET | 1 |
| Blum, HE; Kreisel, W; Opitz, OG; Thimme, R | 1 |
| Chapman, RW; Cullen, SN | 1 |
| Hibi, T; Saito, H; Tada, S | 1 |
| Burakoff, R; Levine, JS | 1 |
| Angulo, P; Charatcharoenwitthaya, P; Enders, FB; Lindor, KD | 1 |
| Batta, AK; Salen, G; Shefer, S; Tint, GS; Xu, G | 1 |
18 review(s) available for ursodeoxycholic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases?
Topics: Animals; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Models, Theoretical; Ursodeoxycholic Acid | 2019 |
Advances in primary sclerosing cholangitis.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Diagnosis, Differential; Endoscopy, Digestive System; Humans; Inflammatory Bowel Diseases; Liver Transplantation; Phenotype; Prognosis; Risk Factors; Ursodeoxycholic Acid | 2016 |
Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Topics: Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Liver Function Tests; Liver Transplantation; Mesalamine; Risk Factors; Ursodeoxycholic Acid | 2018 |
Autoimmune sclerosing cholangitis: Evidence and open questions.
Topics: Adolescent; Adult; Autoantibodies; Autoimmune Diseases; Bile Ducts; Child; Cholangiopancreatography, Endoscopic Retrograde; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Clinical Studies as Topic; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver; Male; Ursodeoxycholic Acid | 2018 |
Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Meta-Analysis as Topic; Prognosis; Ursodeoxycholic Acid | 2013 |
Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis.
Topics: Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Risk Factors; Ursodeoxycholic Acid | 2013 |
[Chemoprevention of colorectal cancer in inflammatory bowel disease].
Topics: Anti-Inflammatory Agents; Chemoprevention; Colorectal Neoplasms; Folic Acid; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Ursodeoxycholic Acid | 2014 |
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Incidence; Inflammatory Bowel Diseases; Prevalence; Prognosis; Risk Assessment; Risk Factors; Ursodeoxycholic Acid | 2014 |
The liver in pediatric gastrointestinal disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Celiac Disease; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cystic Fibrosis; Humans; Infant; Inflammatory Bowel Diseases; Infliximab; Liver Diseases; Liver Function Tests; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
Hepatobiliary associations with inflammatory bowel disease.
Topics: Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Steroids; Ursodeoxycholic Acid | 2009 |
Primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangiography; Cholangitis, Sclerosing; Comorbidity; Disease Progression; Gallbladder Neoplasms; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Inflammatory Bowel Diseases; Linkage Disequilibrium; Liver Cirrhosis; Liver Transplantation; Practice Guidelines as Topic; Prognosis; Risk Factors; Ursodeoxycholic Acid | 2010 |
Recent insights in primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Liver Transplantation; Ursodeoxycholic Acid | 2012 |
Treatment of extraintestinal manifestations in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Anticoagulants; Arthritis; Bone Density Conservation Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Eye Diseases; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Osteoporosis; Skin Diseases; Ursodeoxycholic Acid; Venous Thromboembolism | 2012 |
[Cholestatic liver diseases].
Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid | 2004 |
Review article: current management of primary sclerosing cholangitis.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Combined Modality Therapy; Endoscopy, Digestive System; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Failure; Liver Transplantation; Stents; Ursodeoxycholic Acid | 2005 |
[Primary sclerosing cholangitis].
Topics: Adrenal Cortex Hormones; Autoantibodies; Bacterial Translocation; Cholangitis, Sclerosing; Diagnostic Imaging; Endoscopy, Digestive System; HLA-B8 Antigen; HLA-DR Antigens; Humans; Hypergammaglobulinemia; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver; Liver Transplantation; Prognosis; Reference Standards; Ursodeoxycholic Acid | 2005 |
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex | 2007 |
1 trial(s) available for ursodeoxycholic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
Topics: Adolescent; Adult; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangiography; Cholangitis, Sclerosing; Female; Humans; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid | 2008 |
15 other study(ies) available for ursodeoxycholic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Outcome of pregnancy in patients with primary sclerosing cholangitis.
Topics: Cholangitis, Sclerosing; Female; Humans; Infant, Newborn; Inflammatory Bowel Diseases; Pregnancy; Ursodeoxycholic Acid | 2022 |
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid.
Topics: Abdominal Pain; Aged; Alkaline Phosphatase; Autoimmune Diseases; Budesonide; Crohn Disease; Female; Humans; Ileitis; Inflammatory Bowel Diseases; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid | 2022 |
The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
Topics: Animals; Apoptosis; Cholagogues and Choleretics; Detergents; Disease Models, Animal; Inflammatory Bowel Diseases; Intestinal Mucosa; Lithocholic Acid; Male; Mice; Mice, Inbred C57BL; Permeability; Protective Agents; Ursodeoxycholic Acid | 2020 |
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Mesalamine; Middle Aged; Mortality; Proportional Hazards Models; Protective Factors; Registries; Sweden; Ursodeoxycholic Acid | 2019 |
Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease.
Topics: Animals; Cholagogues and Choleretics; Colon; Drug Carriers; Inflammatory Bowel Diseases; Male; Malondialdehyde; Nanoparticles; Nitric Oxide; Particle Size; Peroxidase; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2014 |
ACG Clinical Guideline: Primary Sclerosing Cholangitis.
Topics: Anti-Infective Agents; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Digestive System Neoplasms; Gallstones; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Ursodeoxycholic Acid | 2015 |
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
Topics: Adult; Aged; Alkaline Phosphatase; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colonoscopy; Dysbiosis; Enterococcus; Feces; Female; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Severity of Illness Index; Statistics as Topic; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Topics: Animals; Bacteroides; Colon; Dextran Sulfate; Disease Models, Animal; Dysbiosis; Feces; Firmicutes; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Mice; Taurine; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2017 |
Understanding of chemoprophylaxis and concordance in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Patient Compliance; Patient Education as Topic; Surveys and Questionnaires; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
Topics: Adolescent; Adult; Aged; Bile Duct Neoplasms; Cholangitis, Sclerosing; Cholestasis; Colorectal Neoplasms; Comorbidity; Female; Follow-Up Studies; Gallbladder Neoplasms; Humans; Incidence; Inflammatory Bowel Diseases; Kaplan-Meier Estimate; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Survival Rate; Ursodeoxycholic Acid; Young Adult | 2010 |
Novel developments in IBD-related sclerosing cholangitis.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cholagogues and Choleretics; Cholangitis, Sclerosing; Disease Progression; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Natalizumab; Ursodeoxycholic Acid | 2011 |
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Kaplan-Meier Estimate; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Norway; Postoperative Period; Preoperative Period; Proportional Hazards Models; Risk Factors; Statistics, Nonparametric; Time Factors; Ursodeoxycholic Acid; Young Adult | 2012 |
Turner syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Esophageal and Gastric Varices; Factor VIII; Female; Gastrointestinal Hemorrhage; Humans; Hypersplenism; Inflammatory Bowel Diseases; Liver Cirrhosis, Biliary; Partial Thromboplastin Time; Platelet Count; Portasystemic Shunt, Surgical; Thrombocytopenia; Turner Syndrome; Ursodeoxycholic Acid; von Willebrand Diseases; von Willebrand Factor | 2002 |
[Primary sclerosing cholangitis. Early dilatation saves lives].
Topics: Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Combined Modality Therapy; Dilatation; Endoscopy; Female; Humans; Inflammatory Bowel Diseases; Male; Radiography; Ursodeoxycholic Acid | 2002 |
Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport, Active; Clostridium perfringens; Colonic Polyps; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Mucosa; Intestines; Mesalamine; Rats; Ursodeoxycholic Acid | 1998 |